Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000433798 | SCV000534249 | likely benign | not specified | 2016-11-30 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000543372 | SCV000638586 | benign | Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intellectual disability, autosomal dominant 9 | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001848792 | SCV002104865 | likely benign | Hereditary spastic paraplegia | 2020-11-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002451046 | SCV002616094 | likely benign | Inborn genetic diseases | 2017-09-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003431010 | SCV004149662 | likely benign | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | KIF1A: BP4, BP7 |
Breakthrough Genomics, |
RCV003431010 | SCV005261923 | likely benign | not provided | criteria provided, single submitter | not provided |